Current findings using rat hearts have implied that the cardioprotective effect induced by urocortin‐1 is mediated by activation of Epac2 (Calderon‐Sanchez et al.,2016) and that Epac2 inhibition promotes cardiac arrhythmias (Yang et al.,2016). The gene discussed is RAPGEF4; the disease is cardiac arrhythmia.